Pfizer buying Medivation in deal valued at about $14B

Monday, August 22, 2016 - 06:31 in Mathematics & Economics

NEW YORK (AP) -- Pfizer is buying the cancer drug company Medivation in a deal valued at about $14 billion....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net